X0306 4 2022-04-18 false 0001531048 Inari Medical, Inc. NARI 0001644989 Hill, Mitch C. C/O INARI MEDICAL, INC. 6001 OAK CANYON, SUITE 100 IRVINE CA 92618 false true false false Chief Financial Officer Common Stock 2022-04-18 4 M false 7500.00 0.457 A 87062.00 D Common Stock 2022-04-18 4 S false 3921.00 86.13 D 83141.00 D Common Stock 2022-04-18 4 S false 2179.00 86.75 D 80962.00 D Common Stock 2022-04-18 4 S false 600.00 88.79 D 80362.00 D Common Stock 2022-04-18 4 S false 800.00 89.54 D 79562.00 D Common Stock 1600.00 I By Spouse Stock Options (Right to buy) 0.457 2022-04-18 4 M false 7500.00 0.457 D 2029-04-23 Common Stock 7500.00 221977.00 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021 This transaction was executed in multiple trades at prices ranging from $85.54 to $86.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $86.54 to $87.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $88.19 to $89.10 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $89.21 to $89.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Options vested with respected with 25% of the underlying shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after. /s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill 2022-04-20